For Immediate Release
View in Browser

CLC (corporate Leadershp Council) NEWS CONTACT: Bobbi Smith
thyroidexec@thyroid.org

Genzyme announces new Thyrogen Co-Pay Assistance Program

November 20, 2015

Subject:  Announcing the new Thyrogen Co-Pay Assistance Program

At Genzyme, we are committed to helping patients obtain access to our therapies – regardless of their ability to pay.

The following programs are available to support patients prescribed Thyrogen® (thyrotropin alfa for injection):

  • The Thyrogen Co-Pay Assistance Program
  • The Thyrogen Patient Assistance Program (PAP)
  • Independent Co-Pay Assistance Foundations

The Thyrogen Co-Pay Assistance Program is designed to support patients with commercial insurance with specific out-of‐pocket costs associated with Thyrogen.

For more information about these programs, please contact ThyrogenONE® at 1-888-497-6436.

Sincerely,

Jamie Petkunas Director, Patient and Product Services

IMPORTANT NOTICE: The Thyrogen Co-Pay Assistance Program does not cover prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other federal or state programs (including any state prescription drug assistance programs). No claim for reimbursement of any out-of-pocket expense amount covered by the Thyrogen Co-Pay Assistance Program may be submitted to any third party payer, whether public or private. The Thyrogen Co-Pay Assistance Program is available only in the United States and cannot be combined with any other rebate/coupon, free trial, or similar offer. Genzyme reserves the right to rescind, revoke, or amend this Program without notice.

Thyrogen® (thyrotropin alfa for injection) Co-Pay Assistance Program – Information for Healthcare Providers (PDF File, 83 KB)


 

Watch us on You Tube Follow us on Twitter Like us on Facebook

American Thyroid Association
6066 Leesburg Pike , Suite 550 , Falls Church, Virginia 22041
Phone 703 998-8890
Email thyroid@thyroid.org
Website www.thyroid.org

You are receiving e-news from the ATA because of your interest in thyroid news.
Click here to avoid receiving future e-mails from us.